Catalyst Event
Ganfeng Lithium Group Co Ltd (1772) · Other
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
6/4/2026, 12:00:00 AM
JPMorgan maintained its "Neutral" rating on Ganfeng Lithium but raised its 2026-2028 earnings forecasts by 15-22%, citing higher long-term lithium price assumptions. This update is estimated to have a low price impact of 1-5% as the rating remains neutral despite the forecast raise, and is forecasted.
Korean Translation
JP모건, 간펑리튬에 대한 '중립' 투자의견을 유지했으나, 분석가들이 예측한 장기 리튬 가격 가정치 상향을 반영하여 2026-2028년 이익 전망을 15-22% 상향 조정함. 이는 투자의견이 중립으로 유지됨에 따라 1-5% 수준의 낮은 주가 영향력을 미칠 것으로 전망됨.
Related Recent Events
Pacific Biosciences of California Inc (PACB) · Earnings Release
Q2 2026 earnings release is scheduled.
8/6/2026, 12:00:00 AM
Pharmaron Beijing Co Ltd (3759) · Other
The ex-dividend date for the RMB 0.20 per share final dividend on July 7, 2026, with payment on August 7, 2026; market reaction is estimated at Low as the payout is within expected ranges scheduled.
7/7/2026, 12:00:00 AM
Jinxin Fertility Group Limited (1951) · Other
Ex-dividend date on 2026-06-29 for the 2025 final dividend of HK$0.0418 per share; Low importance justified by it being a standard technical adjustment scheduled
6/29/2026, 12:00:00 AM
Hansoh Pharmaceutical Group Company Limited (3692) · Other
Annual General Meeting on June 26, 2026, to approve 2025 results and dividends. Analysts estimate a 1-5% price impact for this routine corporate event scheduled.
6/26/2026, 12:00:00 AM
Jinxin Fertility Group Limited (1951) · Other
Annual General Meeting on 2026-06-25 to vote on 2025 financial statements and a HK$0.0418 dividend; Low importance justified by the routine nature of the meeting scheduled
6/25/2026, 12:00:00 AM
Biocytogen Pharmaceuticals (Beijing) Co Ltd (2315) · Other
An extraordinary general meeting is scheduled on 2026-06-25 to vote on a new executive remuneration system and a 10% H-share repurchase mandate; 1% price impact expected.
6/25/2026, 12:00:00 AM